Mallinckrodt To Present At Piper Jaffray 27th Annual Healthcare Conference

Nov 04, 2015, 17:55 ET from Mallinckrodt Pharmaceuticals

CHESTERFIELD, United Kingdom, Nov. 4, 2015 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading specialty biopharmaceutical company, will present on Wednesday, Dec. 2, 2015, at the Piper Jaffray 27th Annual Healthcare Conference at the Lotte New York Palace, 455 Madison Ave., in New York City. The conference is Dec. 1 and 2. 

Matt Harbaugh, Senior Vice President and Chief Financial Officer, and Cole Lannum, Senior Vice President of Investor Strategy and Investor Relations Officer, will represent the company in a 30-minute session scheduled at 11 a.m. Eastern Time.

Individuals who cannot attend the meeting in person can find webcast information at: http://www.mallinckrodt.com/investors. A replay will also be available following the meeting.

ABOUT MALLINCKRODT
Mallinckrodt is a global specialty biopharmaceutical and imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and imaging agents. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. To learn more about Mallinckrodt, visit www.mallinckrodt.com

CONTACTS

Investor Relations
Coleman N. Lannum, CFA
Senior Vice President, Investor Strategy and IRO
314-654-6649
cole.lannum@mallinckrodt.com

Media
Rhonda Sciarra
Senior Manager, Communications
314-654-8618
rhonda.sciarra@mallinckrodt.com

Meredith Fischer
Senior Vice President, Communications and Public Affairs
314-654-3318
meredith.fischer@mallinckrodt.com

Logo - http://photos.prnewswire.com/prnh/20150105/167103LOGO

 

SOURCE Mallinckrodt Pharmaceuticals



RELATED LINKS

http://www.mallinckrodt.com